Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients

The inflammatory cytokines can initiate nerve cell degeneration and enhance the plaque production typically found in Alzheimer's disease (AD). Interleukin-18 (IL-18) is an inflammatory cytokine, which can induce the expression of interferon-gamma. This interleukin shares similarities with the IL-1 family of proteins. Like IL-1 beta, IL-18 is cleaved by caspase-1 (ICE) to an active secreted form. We examined the expressions of IL-18, -1 beta and ICE in different brain regions from AD patients that were categorized with respect to the Braak stage, and age-matched with non-demented controls. The levels of total-RNA and protein of IL-18 and ICE were increased, especially in the frontal lobe of AD patients and this change was not modified by ApoE genotype. Immunohistochemistry of AD brain samples detected IL-18 in microglia, astrocytes, and surprisingly in neurons, and it is also co-localized not only with amyloid-beta plaques but also with tau. In CSF, elevated IL-18 level was detected only in men and it also correlated with CSF tau in MCI. IL-18 may thus be a potential biomarker for men. Plasma levels of IL-18 showed no correlation with the disease. In conclusion, amyloid-beta may induce the synthesis of IL-18, and IL-18 kinases involved in tau phosphorylation as a part of the amyloid-associated inflammatory reaction.

[1]  G. Fantuzzi,et al.  Role of interferon regulatory factor‐1 in the regulation of IL‐18 production and activity , 2001, European journal of immunology.

[2]  R. Schliebs,et al.  Induction of cytokines in glial cells surrounding cortical β-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology , 2000, International Journal of Developmental Neuroscience.

[3]  W. Griffin,et al.  Increased interleukin-1beta converting enzyme expression and activity in Alzheimer disease. , 1998, Journal of neuropathology and experimental neurology.

[4]  Kurt Bürki,et al.  Aβ is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis , 2004, Nature Neuroscience.

[5]  S. Djurovic,et al.  Daily administration of interleukin-18 causes myocardial dysfunction in healthy mice. , 2005, American journal of physiology. Heart and circulatory physiology.

[6]  T. Joh,et al.  Neurons of the superior nucleus of the medial habenula and ependymal cells express IL-18 in rat CNS , 2002, Brain Research.

[7]  M. Hosokawa,et al.  Senescence-accelerated Mouse (SAM): With Special Reference to Development and Pathological Phenotypes. , 1997, ILAR journal.

[8]  J. Attems.  Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms , 2005, Acta Neuropathologica.

[9]  B. Curran,et al.  The pro-inflammatory cytokine interleukin-18 impairs long-term potentiation and NMDA receptor-mediated transmission in the rat hippocampus in vitro , 2001, Neuroscience.

[10]  R. Veerhuis,et al.  Costimulatory Effects of Interferon-γ and Interleukin-1β or Tumor Necrosis Factor α on the Synthesis of Aβ1-40 and Aβ1-42 by Human Astrocytes , 2000, Neurobiology of Disease.

[11]  Hyung-Sik Kang,et al.  IFN-γ Up-Regulates IL-18 Gene Expression Via IFN Consensus Sequence-Binding Protein and Activator Protein-1 Elements in Macrophages1 , 2000, The Journal of Immunology.

[12]  J. Bauer,et al.  IL-6-mediated events in Alzheimer's disease pathology. , 1991, Immunology today.

[13]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[14]  B. Chandrasekar,et al.  Interleukin-18 Is a Pro-hypertrophic Cytokine That Acts through a Phosphatidylinositol 3-Kinase-Phosphoinositide-dependent Kinase-1-Akt-GATA4 Signaling Pathway in Cardiomyocytes* , 2005, Journal of Biological Chemistry.

[15]  Keiichi Higuchi,et al.  A new murine model of accelerated senescence , 1981, Mechanisms of Ageing and Development.

[16]  P. Desjardins,et al.  Expression of ced-3 and ced-9 homologs in Alzheimer"s disease cerebral cortex , 1998, Neuroscience Letters.

[17]  J. Sims,et al.  Binding of interleukin-18 to the interleukin-1 receptor homologous receptor IL-1Rrp1 leads to activation of signaling pathways similar to those used by interleukin-1. , 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[18]  C. Raine,et al.  Multiple sclerosis: Cytokine receptors on oligodendrocytes predict innate regulation , 2004, Annals of neurology.

[19]  R. Mangues,et al.  Brain interleukin-1 beta in Alzheimer's disease and vascular dementia. , 1994, Methods and findings in experimental and clinical pharmacology.

[20]  M. Wolfe,et al.  Tumor Necrosis Factor-α, Interleukin-1β, and Interferon-γ Stimulate γ-Secretase-mediated Cleavage of Amyloid Precursor Protein through a JNK-dependent MAPK Pathway* , 2004, Journal of Biological Chemistry.

[21]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[22]  H. Weiner,et al.  IL-18 is linked to raised IFN-γ in multiple sclerosis and is induced by activated CD4+ T cells via CD40–CD40 ligand interactions , 2002, Journal of Neuroimmunology.

[23]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[24]  I. Alafuzoff,et al.  Human brain tissue microarrays as a platform to investigate diseases of the nervous system , 2006, Brain Research.

[25]  W. Fiers,et al.  Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain? , 1991, Immunology today.

[26]  C. Dinarello,et al.  Elevated Intracranial IL-18 in Humans and Mice after Traumatic Brain Injury and Evidence of Neuroprotective Effects of IL-18—Binding Protein after Experimental Closed Head Injury , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[27]  W. Griffin,et al.  Glial‐Neuronal Interactions in Alzheimer's Disease: The Potential Role of a ‘Cytokine Cycle’ in Disease Progression , 1998, Brain pathology.

[28]  J. Olney,et al.  Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies. , 1997, Archives of neurology.

[29]  T. Joh,et al.  Cultures of astrocytes and microglia express interleukin 18. , 1999, Brain research. Molecular brain research.

[30]  James L. Young,et al.  Expression of Interleukin (IL)-18 and Functional IL-18 Receptor on Human Vascular Endothelial Cells, Smooth Muscle Cells, and Macrophages , 2002, The Journal of experimental medicine.

[31]  Richard Mohs,et al.  Caspase gene expression in the brain as a function of the clinical progression of Alzheimer disease. , 2003, Archives of neurology.

[32]  Richard Hollister,et al.  Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease , 1997, Annals of neurology.

[33]  D. Borchelt,et al.  Accelerated Amyloid Deposition in the Brains of Transgenic Mice Coexpressing Mutant Presenilin 1 and Amyloid Precursor Proteins , 1997, Neuron.

[34]  T. Teramoto,et al.  Determination by PCR-RFLP of apo E genotype in a Japanese population. , 1993, The Journal of laboratory and clinical medicine.

[35]  N. Horwood,et al.  Interleukin-18: perspectives on the newest interleukin. , 1998, Cytokine & growth factor reviews.

[36]  N. Rothwell,et al.  Identification of a truncated IL-18Rβ mRNA: a putative regulator of IL-18 expressed in rat brain , 2003, Journal of Neuroimmunology.

[37]  Z. Khachaturian.  Diagnosis of Alzheimer's disease. , 1985, Archives of neurology.

[38]  A. Placzek,et al.  Alzheimer's β-amyloid peptides induce inflammatory cascade in human vascular cells: the roles of cytokines and CD40 , 1998, Brain Research.

[39]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[40]  J. Wood,et al.  Functional studies of Alzheimer's disease tau protein , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[41]  M. Schultzberg,et al.  Soluble interleukin-1 receptor type II, IL-18 and caspase-1 in mild cognitive impairment and severe Alzheimer's disease , 2005, Neurochemistry International.

[42]  H. Tanila,et al.  Hippocampal Aβ42 Levels Correlate with Spatial Memory Deficit in APP and PS1 Double Transgenic Mice , 2002, Neurobiology of Disease.

[43]  F. Nicoletti,et al.  Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia , 2006, The European journal of neuroscience.

[44]  H. Okamura,et al.  Cloning of a new cytokine that induces IFN-γ production by T cells , 1995, Nature.

[45]  M. Mattson,et al.  Amyloid ox–tox transducers , 1996, Nature.

[46]  T. Uehara,et al.  Changes in expressions of proinflammatory cytokines IL-1β, TNF-α and IL-6 in the brain of senescence accelerated mouse (SAM) P8 , 2000, Brain Research.

[47]  L. Joosten,et al.  Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis. , 2003, Arthritis and rheumatism.